Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
1 clinical trials · Condition
◉ Watch Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
| Record | Firm | Date |
|---|---|---|
| Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients (NCT03053635) | Theralase® Technologies Inc. | 2016-12-21 |
Track Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG automatically
Every clearance here is in the API, with alerts when new ones post.